Bowel Regimen for Constipation
For chronic idiopathic constipation in adults, start with polyethylene glycol (PEG) 17g once daily as first-line therapy, which provides superior efficacy and safety compared to other laxatives. 1
First-Line Treatment Algorithm
Mild Constipation (Fiber-Deficient Diet)
- Psyllium 5-10g daily (divided into 1-3 doses) can be tried initially for mild symptoms, taken with 8-10 ounces of fluid per dose 1, 2
- Psyllium increases spontaneous bowel movements by 2.32 per week and improves global symptom relief (RR 1.86) 2
- Key limitation: Fiber causes flatulence and requires adequate fluid intake; avoid in patients with low fluid consumption 1
Moderate-to-Severe Constipation (Recommended Starting Point)
- PEG 17g in 8 oz water once daily is the recommended first-line agent 1, 3
- PEG increases complete spontaneous bowel movements by 2.90 per week (95% CI 2.12-3.68) and total bowel movements by 2.30 per week 1
- Response is durable over 6 months with minimal side effects (abdominal distension, loose stool, flatulence, nausea) 1
- Can dose twice daily (17g BID) if once daily is insufficient 3
Second-Line Options for Persistent Constipation
Stimulant Laxatives
- Bisacodyl 10-15mg daily, targeting one non-forced bowel movement every 1-2 days 1, 3
- Can increase to 10-15mg two to three times daily for persistent symptoms 3
- Senna 15-30mg daily (typically 2 tablets twice daily) as alternative stimulant 3, 4
- Critical warning: Prolonged stimulant use causes colonic dependency and rebound constipation; transition to osmotic agents if needed long-term 5
Alternative Osmotic Laxatives
- Lactulose 30-60mL twice to four times daily 5
- Magnesium hydroxide 30-60mL daily to twice daily 5
- Caution: Avoid magnesium-based laxatives in renal impairment due to hypermagnesemia risk 3, 5
Rectal Interventions for Impaction
When fecal impaction is identified on digital rectal exam:
- Glycerin suppository as first-line rectal intervention 3
- Bisacodyl suppository 10mg rectally once or twice daily 3
- Manual disimpaction with premedication (analgesic ± anxiolytic) if suppositories fail 3
Prescription Therapies for Refractory Cases
Intestinal Secretagogues (IBS-C or Refractory CIC)
- Linaclotide 145mcg once daily for chronic idiopathic constipation (can reduce to 72mcg for tolerability) 1, 6
- Linaclotide 290mcg once daily for IBS with constipation 6
- Take on empty stomach at least 30 minutes before meals 6
- Most efficacious secretagogue available, though diarrhea is common side effect 1
Alternative Secretagogues
- Lubiprostone (chloride channel activator) - less likely to cause diarrhea than linaclotide but nausea is frequent 1
- Plecanatide or tenapanor - similar efficacy to linaclotide with comparable diarrhea rates 1
Opioid-Induced Constipation Specific Management
- Start prophylactic stimulant laxative with first opioid dose 3
- Combine stimulant (senna or bisacodyl) with stool softener as indicated 1
- For laxative-refractory cases: Methylnaltrexone 0.15mg/kg subcutaneously every other day (maximum once daily) 1, 3
- Contraindication: Do NOT use fiber/psyllium in opioid-induced constipation as it may worsen symptoms 4
Essential Supportive Measures
- Increase fluid intake to at least 2 liters daily - particularly critical for those in lowest quartile of fluid consumption 1, 3, 5
- Encourage physical activity within patient limitations 1, 3
- Dietary fiber increase only if adequate fluid intake maintained 5
- Ensure toilet access and educate patients to attempt defecation twice daily, 30 minutes after meals, straining no more than 5 minutes 5
Critical Pitfalls to Avoid
- Always rule out bowel obstruction, fecal impaction, hypercalcemia, hypokalemia, hypothyroidism, and diabetes before escalating therapy 1, 5
- Never use enemas in patients with recent colorectal or gynecological surgery 3
- Avoid bulk-forming laxatives in postoperative patients with limited mobility or fluid intake due to obstruction risk 3
- Discontinue stimulant laxatives immediately if rebound constipation develops and transition to PEG 5
- Fiber requires 4+ weeks at doses >10g/day for optimal effect - inadequate trial duration is common error 2